1,2-Dichloroethane → 1-Amino-6-cyclopropyl-N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-1H-pyrazolo[3,4-b]pyridine-4-carboxamide
Reaction equation
[NH2:1][N:2]1[C:6]2[N:7]=[C:8]([CH:14]3[CH2:16][CH2:15]3)[CH:9]=[C:10]([C:11]([OH:13])=O)[C:5]=2[CH:4]=[N:3]1.[NH2:17][CH2:18][C:19]1[C:20](=[O:27])[NH:21][C:22]([CH3:26])=[CH:23][C:24]=1[CH3:25].ON1C2N=CC=CC=2N=N1.C(Cl)CCl.CN1CCOCC1>CS(C)=O>[NH2:1][N:2]1[C:6]2[N:7]=[C:8]([CH:14]3[CH2:16][CH2:15]3)[CH:9]=[C:10]([C:11]([NH:17][CH2:18][C:19]3[C:20](=[O:27])[NH:21][C:22]([CH3:26])=[CH:23][C:24]=3[CH3:25])=[O:13])[C:5]=2[CH:4]=[N:3]1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
The title compound was prepared in the same manner as described for intermediate 56 using 1-amino-6-cyclopropyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid (73 mg, 0.335 mmol), 3-(aminomethyl)-4,6-dimethyl-2(1H)-pyridinone (76 mg, 0.502 mmol), 1-hydroxy-7-azabenzotriazole (91 mg, 0.669 mmol), DMSO (10 mL), EDC (128 mg, 0.669 mmol), and N-methylmorpholine (0.147 mL, 1.338 mmol). The aq. phase was extracted with EtOAc (5×30 mL). The combined EtOAc extracts were dried over MgSO4, filtered, and concentrated in vacuo. The final product was collected as 0.068 g (58%). LCMS E-S (M+H)=353.3. 1H NMR (400 MHz, DMSO-d6) δ ppm 0.99-1.14 (m, 4H), 2.13 (s, 3H), 2.22 (s, 4H), 4.35 (d, J=4.80 Hz, 2H), 5.90 (s, 1H), 6.31 (s, 2H), 7.41 (s, 1H), 8.04 (s, 1H), 8.74 (s, 1H), 11.58 (br. s., 1H).
Workup
- extractionThe aq. phase was extracted with EtOAc (5×30 mL)
- dry with materialThe combined EtOAc extracts were dried over MgSO4
- filtrationfiltered
- concentrationconcentrated in vacuo
- customThe final product was collected as 0.068 g (58%)
Sources & evidence
- ORD record
- ord-b4dc959f5a564e039a2779fb23e4cd6d
- Source dataset
- uspto-grants-2014_01
- Patent number
- US08637509B2
Reaction notes
Loading…